{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:32:04Z","timestamp":1782495124828,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JP17ek0109088h00"],"award-info":[{"award-number":["JP17ek0109088h00"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.mito.2019.02.001","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T09:38:36Z","timestamp":1549791516000},"page":"11-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6664-1295","authenticated-orcid":false,"given":"Yasutoshi","family":"Koga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Povalko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Nashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mito.2019.02.001_bb0005","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10575","article-title":"Mitochondrial dysfunction remodels one-carbon metabolism in human cells","author":"Bao","year":"2016","journal-title":"elife"},{"issue":"1","key":"10.1016\/j.mito.2019.02.001_bb0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1083\/jcb.201607110","article-title":"Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis","volume":"216","author":"Chung","year":"2017","journal-title":"J. Cell Biol."},{"issue":"21","key":"10.1016\/j.mito.2019.02.001_bb0020","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.0000000000002705","article-title":"A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases","volume":"86","author":"Davis","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mito.2019.02.001_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ymgme.2014.04.008","article-title":"Efficacy of pyruvate therapy in patients with mitochondrial disease: a semi-quantitative clinical evaluation study","volume":"112","author":"Fujii","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2019.02.001_bb0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mito.2014.10.006","article-title":"GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases","volume":"20","author":"Fujita","year":"2015","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.mito.2019.02.001_bb0035","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1210\/jc.2015-4293","article-title":"Pyruvate improved insulin secretion status in a mitochondrial diabetes mellitus patient","volume":"101","author":"Inoue","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.mito.2019.02.001_bb0040","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.mito.2012.07.113","article-title":"Metabolomic profiling rationalized pyruvate efficacy in cybrid cells harboring MELAS mitochondrial DNA mutations","volume":"12","author":"Kami","year":"2012","journal-title":"Mitochondrion"},{"issue":"3","key":"10.1016\/j.mito.2019.02.001_bb0045","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/01.wnl.0000196641.05913.27","article-title":"Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial","volume":"66","author":"Kaufmann","year":"2006","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.mito.2019.02.001_bb0050","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1212\/WNL.0b013e31823a0c7f","article-title":"Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype","volume":"77","author":"Kaufmann","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2019.02.001_bb0055","first-page":"69","article-title":"Serum GDF15 levels correlate to mitochondrial disease severity and myocardial strain, but not to disease progression and adult m.3243>G carriers","volume":"24","author":"Koene","year":"2015","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.mito.2019.02.001_bb0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.braindev.2011.03.003","article-title":"Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1\u03b1 gene","volume":"34","author":"Koga","year":"2012","journal-title":"Brain Dev."},{"issue":"3","key":"10.1016\/j.mito.2019.02.001_bb0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbagen.2009.07.008","article-title":"Pyruvate therapy for Leigh syndrome due to cytochrome c oxidase deficiency","volume":"1800","author":"Komaki","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.mito.2019.02.001_bb0070","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.2337\/db17-0333","article-title":"Growth differentiation factor 15 mediates systemic glucose regulatory action of T-Helper type 2 cytokines","volume":"66","author":"Lee","year":"2017","journal-title":"Diabetes"},{"issue":"1\u20132","key":"10.1016\/j.mito.2019.02.001_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymgme.2006.05.015","article-title":"Lactic acidemia and mitochondrial disease","volume":"89","author":"Robinson","year":"2006","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.mito.2019.02.001_bb0080","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbagen.2011.08.006","article-title":"Pyruvate therapy for mitochondrial DNA depletion syndrome","volume":"1820","author":"Saito","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.mito.2019.02.001_bb0085","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1212\/01.wnl.0000219759.72195.41","article-title":"Mitochondrial disease in adults: a scale to monitor progression and treatment","volume":"66","author":"Schaefer","year":"2006","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.mito.2019.02.001_bb0090","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","article-title":"FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study","volume":"10","author":"Suomalainen","year":"2011","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.mito.2019.02.001_bb0095","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.mito.2007.07.002","article-title":"Therapeutic potential of pyruvate therapy for mitochondrial diseases","volume":"7","author":"Tanaka","year":"2007","journal-title":"Mitochondrion"},{"issue":"6282","key":"10.1016\/j.mito.2019.02.001_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1126\/science.aad4017","article-title":"Complementation of mitochondrial electron transport chain by manipulation of the NAD+\/NADH ratio","volume":"352","author":"Titov","year":"2016","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mito.2019.02.001_bb0105","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1042\/bj1030514","article-title":"The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver","volume":"103","author":"Williamson","year":"1967","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.mito.2019.02.001_bb0110","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","article-title":"MELAS: a nationwide prospective cohort study of 96 patients in Japan","volume":"1820","author":"Yatsuga","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.mito.2019.02.001_bb0115","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ana.24506","article-title":"Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders","volume":"78","author":"Yatsuga","year":"2015","journal-title":"Ann. Neurol."}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724918301168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724918301168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:22:39Z","timestamp":1761589359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724918301168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":22,"alternative-id":["S1567724918301168"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2019.02.001","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2019.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}